MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon.

MxA gene expression is known to be regulated tightly and exclusively by type I interferons (IFNs). The kinetics of MxA gene expression was analyzed in peripheral blood mononuclear cells from 11 healthy volunteers vaccinated with the 17-D strain of yellow fever virus. A reliable induction of MxA RNA and MxA protein was found in the absence of easily detectable serum IFN activity. Thus, steady-state MxA RNA levels were elevated 8- to 30-fold above prevaccination levels on day 5 after vaccination. The average increase of MxA protein was approximately 50-fold. In contrast, no induction of MxA RNA or MxA protein was detectable in 3 similarly vaccinated controls who were immune because of previous vaccinations. The IFN marker 2'-5'-oligoadenylate (2-5A) synthetase known to react to both type I and type II IFNs showed a similar response but did not differentiate equally well between nonimmune and immune vaccinees. beta 2-microglobulin and neopterin reacted poorly, remaining at low levels within the normal range. These results demonstrate that MxA gene expression is a good marker for detecting minute quantities of biologically active type I IFN during viral infections.

[1]  V. ter meulen,et al.  MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line , 1993, Journal of virology.

[2]  P. Staeheli,et al.  Mx proteins: GTPases with antiviral activity. , 1993, Trends in cell biology.

[3]  K. Melén,et al.  Control of IFN-inducible MxA gene expression in human cells. , 1993, Journal of immunology.

[4]  M. Horisberger Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins , 1992, Journal of virology.

[5]  A. Schmitz,et al.  A whole blood immunoassay for the interferon-inducible human Mx protein. , 1992, Journal of Interferon Research.

[6]  S. Baron Interferon : principles and medical applications , 1992 .

[7]  O. Haller,et al.  Mx genes show weaker primary response to virus than other interferon-regulated genes. , 1992, Virology.

[8]  O. Haller,et al.  Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines , 1991, Journal of virology.

[9]  D. Näf,et al.  A Novel, Quantitative Bioassay for Type I Interferon Using a Recombinant Indicator Cell Line , 1990, Bio/Technology.

[10]  H. Hochkeppel,et al.  Correlation of the antiproliferative effect and the Mx-homologous protein induction by IFN in patients with malignant melanoma. , 1990, The Journal of investigative dermatology.

[11]  H. Hochkeppel,et al.  The human intracellular Mx‐homologous protein is specifically induced by type I interferons , 1990, European journal of immunology.

[12]  M. Lindstrom,et al.  Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages. , 1990, Journal of interferon research.

[13]  O. Haller,et al.  Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein , 1990, Journal of virology.

[14]  H. Hochkeppel,et al.  Emergence and decay of the human Mx homolog in cancer patients during and after interferon-alpha therapy. , 1990, Journal of biological response modifiers.

[15]  H. Hochkeppel,et al.  The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection. , 1990, AIDS.

[16]  O. Haller,et al.  Akkumulation von Mx-mRNA als Maß für die biologische Wirksamkeit von Interferon , 1990 .

[17]  P. Staeheli Interferon-induced proteins and the antiviral state. , 1990, Advances in virus research.

[18]  H. Hochkeppel,et al.  MX HOMOLOGOUS PROTEIN IN MONONUCLEAR CELLS FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS , 1989, Arthritis and rheumatism.

[19]  H. Zeller,et al.  Regulation of the interferon-inducible IFI-78K gene, the human equivalent of the murine Mx gene, by interferons, double-stranded RNA, certain cytokines, and viruses , 1989, Journal of Virology.

[20]  E. Borden,et al.  Enhancement of indoleamine 2,3-dioxygenase activity in cancer patients receiving interferon-beta Ser. , 1989, Journal of interferon research.

[21]  E. Borden,et al.  Accumulation of guanylate binding proteins in patients treated with interferons. , 1988, Journal of interferon research.

[22]  J. Gugenheim,et al.  Interferon messenger RNA is produced constitutively in the organs of normal individuals. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[24]  J. Sutcliffe,et al.  Transcriptional activation of the mouse Mx gene by type I interferon , 1986, Molecular and cellular biology.

[25]  M. Aguet,et al.  Absence of detectable serum interferon in acute and chronic viral hepatitis , 1986, Hepatology.

[26]  J. Vannier,et al.  Enhanced level of double-stranded RNA-dependent protein kinase in peripheral blood mononuclear cells of patients with viral infections. , 1986, Journal of interferon research.

[27]  M. Pignatelli,et al.  Viruses and immune reactions in the liver. , 1985, Scandinavian journal of gastroenterology. Supplement.

[28]  V. Gerein,et al.  (2'-5')oligo(A) synthetase as a monitor of interferon action in juvenile laryngeal papillomatosis. , 1984, Journal of interferon research.

[29]  D. Fuchs,et al.  Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases. , 1983, Transplantation.

[30]  J. Goedert,et al.  Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia. , 1983, The New England journal of medicine.

[31]  A. Hovanessian,et al.  Assay and the levels of 2-5A-synthetase in lymphocytes of patients with viral, bacterial and autoimmune diseases. , 1983, Annales d'immunologie.

[32]  R. Friedman,et al.  Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. , 1982, Science.

[33]  D. Wallach,et al.  ASSAY OF AN INTERFERON-INDUCED ENZYME IN WHITE BLOOD CELLS AS A DIAGNOSTIC AID IN VIRAL DISEASES , 1981, The Lancet.

[34]  J. Parry,et al.  INTERFERON ASSAY AS A DIAGNOSTIC TEST , 1981, The Lancet.

[35]  S. Pestka,et al.  Convenient assay for interferons , 1981, Journal of virology.

[36]  D. Wallach,et al.  Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells. , 1981, Journal of interferon research.

[37]  P. Evrin,et al.  Serum 2 -microglobulin in various disorders. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[38]  R. Purcell,et al.  Failure to Demonstrate Circulating Interferon During Incubation Period and Acute Stage of Transfusion-Associated Hepatitis , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[39]  Wheelock Ef,et al.  CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS. , 1965 .

[40]  T. Merigan,et al.  CIRCULATING INTERFERON AFTER MEASLES VACCINATION. , 1965, The New England journal of medicine.

[41]  W. Sibley,et al.  CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS. , 1965, The New England journal of medicine.